Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-09-14Clinical Trial Update: Database of Patients Undergoing Cardiac Computed Tomographic Angiography at William Beaumont Hospital (CT DATABASE)
This completed clinical trial database update catalogs patients undergoing cardiac computed tomographic angiography at William Beaumont Hosp…
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: Inflammation and Acute Coronary Syndromes
This clinical trial update from the University of Zurich concerns inflammation in acute coronary syndromes. No trial results or current stat…
-
FDA label_change · 2016-09-07FDA Approved: AGGRASTAT — Supplemental Application (Medicure International Inc)
FDA approved a supplemental application for AGGRASTAT (tirofiban) submitted by Medicure International Inc, resulting in changes to the produ…
-
CLINICAL_TRIALS research · 2016-09-07Clinical Trial Update: Observatory on Emergency Care for Acute Coronary Syndrome in Grand Est of France
Observatory on Emergency Care for Acute Coronary Syndrome in the Grand Est region, France, is an observational clinical trial sponsored by C…
-
CLINICAL_TRIALS research · 2016-08-24Clinical Trial Update: Vascular Inflammation Imaging Using Somatostatin Receptor Positron Emission Tomography
A completed study evaluated vascular inflammation imaging using a somatostatin receptor PET tracer in patients with cardiovascular and cereb…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-08-18Clinical Trial Update: BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM
Post-market BMX Alpha Registry is monitoring outcomes in patients with coronary disease and ischemic conditions after BioMatrix Alpha stent …
-
FDA approval · 2016-08-11FDA Approved: BRILINTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Brilinta (ticagrelor) from AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS research · 2016-08-04Clinical Trial Update: Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome [Phase 4]
Clinical Trial Update describes a Phase 4 study comparing simvastatin with fenofibrate versus simvastatin alone in patients with Type 2 diab…
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Better Evaluation of Acute Chest Pain With Computed Tomography Angiography [NA]
A completed clinical trial update evaluating computed tomography angiography to improve the evaluation of acute chest pain and suspected acu…
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: Ticagrelor in Fuwai Hospital
A clinical trial of ticagrelor at Fuwai Hospital for Acute Coronary Syndrome; no current status information is provided.
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: BLeeding Events and Maintenance DoSe of PraSugrel [Phase 4]
A Phase 4 trial evaluating the maintenance dosing of prasugrel reported bleeding events. The study has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronary Atherosclerosis
An update on a clinical trial evaluating the effect and efficacy of the Xpedition/Alpine everolimus-eluting stent for coronary atheroscleros…
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents [Phase 4]
Phase 4 trial update evaluating neointimal coverage after implantation of a Biolimus-eluting stent with biodegradable polymer. The study use…
-
FDA approval · 2016-07-22FDA Approved: BRILINTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for BRILINTA (ticagrelor) submitted by AstraZeneca Pharmaceuticals LP. The action concerns a supplem…
-
CLINICAL_TRIALS research · 2016-07-19Clinical Trial Update: Validation of Simple Acute Coronary Syndrome (SACS) Score
This clinical trial update reports on the validation of the Simple Acute Coronary Syndrome (SACS) Score for assessing patients with chest pa…
-
FDA approval · 2016-07-12FDA Approved: EFFIENT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA has approved a supplemental application for Effient (prasugrel hydrochloride) submitted by Cosette Pharmaceuticals, Inc. This action…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Antithrombotic Effects of Ticagrelor Versus Clopidogrel [Phase 4]
Phase 4 trial comparing the antithrombotic effects of ticagrelor versus clopidogrel in patients with acute coronary syndrome; results were p…
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Imaging Whole Coronary Artery With Intravascular Ultrasound (Ivus) And Imap For Plaque Tissue Composition In Patients With Acute Myocardial Infarction [NA]
This clinical trial update reports completion of a study evaluating whole coronary artery imaging with intravascular ultrasound (IVUS) and I…
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study [Phase 4]
Phase 4 pharmacogenomics study of anti-platelet intervention (PAPI-2) was terminated; results posted in 2016.
-
CLINICAL_TRIALS research · 2016-06-21Clinical Trial Update: Acute Coronary Syndrome Genetic Study
This is a clinical trial update for a genetic study related to Acute Coronary Syndrome sponsored by Peking University First Hospital. The tr…
-
FDA approval · 2016-06-16FDA Approved: AGGRASTAT — Supplemental Application (Medicure International Inc)
FDA approved a supplemental application for AGGRASTAT (tirofiban) submitted by Medicure International Inc. The action updates the drug's lab…
-
CLINICAL_TRIALS trial_result · 2016-06-16Clinical Trial Update: The Effect of DPP4 Inhibitor on Vasclular Healing [Phase 4]
Phase 4 clinical trial evaluating the effect of a DPP-4 inhibitor on vascular healing in patients with acute coronary syndrome and type 2 di…
-
CLINICAL_TRIALS trial_result · 2016-06-07Clinical Trial Update: Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI [Phase 4]
Phase 4 clinical trial comparing ticagrelor versus clopidogrel for myocardial salvage in patients with ST-elevation myocardial infarction un…
-
CLINICAL_TRIALS research · 2016-06-02Clinical Trial Update: Increasing Exercise Adherence After Percutaneous Coronary Intervention With the Fitbit Charge HR Device [NA]
A clinical trial evaluating whether use of the Fitbit Charge HR device improves exercise adherence after percutaneous coronary intervention …
-
CLINICAL_TRIALS research · 2016-06-01Clinical Trial Update: Pharmacist-led Intervention to Enhance Medication Adherence in Post-acute Coronary Syndrome Patients in Vietnam [NA]
An ongoing clinical trial in Vietnam tests a pharmacist-led intervention to improve medication adherence in post-acute coronary syndrome pat…